Clinical Trial Update: PEG-ASP, Etoposide and Gemcitabine for Natural Killer/T Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a regimen of PEG-ASP, etoposide, and gemcitabine for natural killer/T-cell lymphoma is reported, with the status currently unk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Natural Killer T-cell Lymphoma

Drugs mentioned

• PEG-ASP, etoposide and gemcitabine

Snippet

Sponsor: Sun Yat-sen University | Conditions: Treatment Refusal | Phase 2 | Status: UNKNOWN